FDA Approves Multaq to Treat Heart Rhythm Disorder

Links shared publicly online about this topic.

1,927
total visits

FDA Approves Multaq to Treat Heart Rhythm Disorder

The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders). The drug is approved to be used in patients whose hearts have returned to normal rhythm or who will undergo drug or electric-shock treatment to restore a normal heart beat.

View full resource at fda.gov

Tags: Heart, Eye, Disease and Condition, Drug, FDA, Antiarrhythmic Medication, Multaq

Most Recently Shared on July 7, 2009 at 2:06 am By:

M Auron MD

Finally, Dronedarone is on the market. Let's see its adverse effects in a few years. Lawyers will keep an eye on it! - http://bit.ly/iEJVQ

3 years ago...

Retweet

Favorite

Also Shared By:

eyeonfda

FDA OKs Medtronic system for atrial fibrillation | Reuters

reuters.com — “NEW YORK (Reuters) - Medical device maker Medtronic Inc said U.S. regulators approved its new catheter system for treating a common heart rhythm disorder known as paroxysmal atrial fibrillation. The Food” View full resource at reuters.com

Most Recently Shared on December 20, 2010 at 12:39 am By:

Drugs and Devices OW OW Health

FDA OKs Medtronic system for atrial fibrillation: NEW YORK (Reuters) - Medical device maker Medtronic Inc said U... http://bit.ly/gnh2ec

1 year ago...

Retweet

Favorite

FDA OKs Medtronic system for atrial fibrillation | Reuters

Most Recently Shared on December 18, 2010 at 12:00 am By:

Hisham Rana, MD Doctor and Physician

News: FDA OKs Medtronic Arctic Front Cardiac CryoAblation Catheter system for paroxysmal atrial fibrillation http://reut.rs/hLn7qW - #health

1 year ago...

Retweet

Favorite